["%3 HS bolus","%3 HS infusion 20 ml\/h","(177Lu-DOTAOTyr3)Octreotate","(18F)MFBG","0.1 mg GnRH agonist","0.5 mg estradiol \/ 0.1 mg norethindrone acetate","0.5 mg Ranibizumab","0.75% Ropivacaine","06Benzylguanine","1 mg estradiol \/ 0.5 mg norethindrone acetate","1% Xylocaine","10 mg Melatonin","100 mg\/m2 aldoxorubicin","11.25mg GnRH agonist","111In-CP04","111In-CP04 with co-administration of gelofusine\/gelaspan","12 mg\/kg \u03b1-TEA","12.5 mg Proellex","1200mg of TQB2928 injection+Anlotinib","123I-meta-iodobenzylguanidine","123I-mIBG (meta-iodobenzylguanidine)","124I-Metaiodobenzylguanidine (MIBG) (no-carrier added)","124I-MIBG (carrier added)","124I-NM404","13-cis-retinoic acid","131 I-Metaiodobenzylguanidine","131 I-Metaiodobenzylguanidine (131I-MIBG)","131-I-chTNT-1\/B MAB","131-I-meta-iodobenzylguanidine","131I-8H9","131I-MIBG","131I-MIBG, Etoposide, Melphalan, Carboplatin, Autologous Peripheral Stem Cell Transplantation","131I-Omburtamab","1327 microCi of 225Ac-MTI-201","13C-glucose","14C-Labeled Vemurafenib","150 mg\/m2 aldoxorubicin","152 microCi of 225Ac-MTI-201","153-Sm-DOTMP (Samarium-153-DOTMP)","16 weeks of VEC + CDDP","16.8 mg\/kg \u03b1-TEA","161Tb-DOTA-LM3","170 mg\/m2 aldoxorubicin","177Lu-DOTA-EB-TATE","177Lu-DOTA-EB-TATE 1","177Lu-DOTA-EB-TATE 2","177Lu-DOTA-EB-TATE 3","177Lu-DOTA-TATE","177Lu-DOTA0-Tyr3-Octreotate","177Lu-DOTATATE","177Lu-DOTATATE 18.5 GBq activity","177Lu-DOTATATE 25.9 GBq activity","177Lu-Dotatate PRRT","177Lu-DOTATOC","177Lu-DTPA-omburtamab","177Lu-edotreotide PRRT","177Lu-FAP-2286","18-F FTC 146","1800mg of TQB2928 injection+Anlotinib","18F-AlF-NOTA-octreotide","18F-DA","18F-DCFPyL Injection","18F-DOPA","18F-FAZA","18F-FAZA (F18-Fluoroazomycin Arabinoside)","18F-fluciclovine","18F-fludeoxyglucose (18F-FDG)","18F-FMISO","18F-FPPRGD2","18F-MFBG","18F-PFPN","19 microCi of 225Ac-MTI-201","19.2 mg\/kg \u03b1-TEA","2 doses 400 microgram misoprostol","2 Doses Goserelin","2-OHOA","2.4 mg\/kg \u03b1-TEA","20 mg Melatonin","20% mannitol","212-Lead Pentixather","2141 V11","2141-V11","22.3 mg\/kg \u03b1-TEA","25 mg Proellex","25 \u00b5g transdermal oestradiol","250 mg\/m2 aldoxorubicin","254 microCi of 225Ac-MTI-201","26.8 mg\/kg \u03b1-TEA","3 Doses Goserelin","3-[18F]Fluoro-para-hydroxyphenethylguanidine","38 microCi of 225Ac-MTI-201","3F8 and 13-cis-retinoic acid","3F8 monoclonal antibody and 13-cis-Retinoic Acid","3F8 Monoclonal Antibody Combined with Interleukin-2","4.7 microCi 225Ac-MTI-201","4.8 mg\/kg \u03b1-TEA","424 microCi of 225Ac-MTI-201","5 Aminolevulinic Acid","5 Azacytidine","5% bupivacaine","5-aminolevulinic acid (5-ALA)","5-AMINOLEVULINIC ACID (5-ALA), is a non fluorescent prodrug.","5-aminolevulinic acid nanoemulsion","5-Azacytidine","5-Azacytidine and trastuzumab infusion","5-fluorouracil","5-fluorouracil, Calcium folinate and Irinotecan","5-FU","5-FU, Oxaliplatin, Leukovorin (FLO)","50 mg\/m2 aldoxorubicin","500 mg [14C]-LX1606","564 microCi of 225Ac-MTI-201","5HT3 receptor antagonist","6,8-Bis(benzylthio)octanoic Acid","609A","64Cu-DOTATATE","64Cu-SARTATE","67Cu-SARTATE","68-Ga-DOTANOC","68-Gallium DOTATATE","68Ga-DOTA-TOC","68Ga-DOTATATE","68Ga-DOTATOC","68Ga-DOTATOC PET\/C","68Ga-DOTATOC PET\/CT","68Ga-DOTATOC PET\/CT Scan","68Ga-FAP-2286","68Ga-grazytracer","68Ga-NeoBOMB1, 2-vial kit","68Ga-NOTA-RM26","68Ge\/68Ga Generator","7-hydroxystaurosporine","750 microCi of 225Ac-MTI-201","75mg selumetinib","76 microCi of 225Ac-MTI-201","8.0 mg\/kg \u03b1-TEA","89Zr-bevacizumab","8H9","9-ING-41","9.5 microCi of 225Ac-MTI-201","9.6 mg\/kg \u03b1-TEA","90Y DOTATATE and 177Lu DOTATATE (mix each of 50%)","90Y-DOTA-3-Tyr-Octreotide","90Y-DOTA-TOC","90Y-DOTA-tyr3-Octreotide","90Y-DOTATATE","90Y-SMT487","998 microCi of 225Ac-MTI-201","A-007","Abacavir","abacavir \/3TC plus ritonavir boosted lopinavir","abacavir\/3TC\/zidovudine","Abandonment of intravenous volume expansion during preoperative preparation in patients with pheochromocytoma","ABBV-085","ABC294640","Abemaciclib","Abemaciclib 200 MG","ABI-009","Abiraterone","Abiraterone Acetate","Abraxane","Abraxane combined with liposomal doxorubicin","ABT-414","ABT-510 - Thrombospondin-1 mimetic","ABT-751","ABT-888","ABY-029","acenocoumarol","Acetaminophen","Acetazolamide","Acetylcholine","acetylcysteine","acid Zoledronic","ACT001","ACT001 + Pembrolizumab","Actinomycin D","Active Comparator: Vinblastine and Methotrexate","ACTM-838","Adagrasib","Adalimumab","Adavosertib","ADCT-601","ADI PEG20","ADI-PEG20","Adjuvant chemotherapy by Fotemustin","Adjuvant nivolumab","Adjuvant nivolumab IV + nivolumab and ipililumab intracavitary","Adjuvant therapy","ADM","ADM Plus IFO or IFO Alone","ADR-529","Adriamycin","Adriamycin (Doxorubicin)","Adriamycin-based chemotherapy","AdVince","AEB071","afatinib","Aflibercept Injection","AG-120","agatolimod sodium","AI or TAM","AIM regimen \/ GT regimen","AK105","Akt Inhibitor MK2206","Akt\/ERK Inhibitor ONC201","AL102","Al18F-NOTA-octreotide","AL2846 capsules","AL3818","AL3818 or placebo","albumin paclitaxel","Albumin-Bound Paclitaxel","Aldesleukin","aldoxorubicin","Alectinib","Alemtuzumab","Alimta","Alisertib","Alitretinoin","Alkylating-based chemotherapy","All patients- TAS-102","all-trans retinoic acid (ATRA)","allogeneic lymphocytes","allovectin-7","allovectin-7\/dacarbazine","ALMB-0168","alpelisib","AlphaMedix","altretamine","alvespimycin hydrochloride","alvocidib","Ambulatory Oxygen","AMG 102 at 10 mg\/kg","AMG 102 at 20 mg\/kg","AMG 337","AMG 386","AMG 404","AMG 479","AMG 596","AMG 650","AMG 655","AMG 706","Amifostine","amifostine trihydrate","amifostine\/azacitidine","Amino Acids","aminocamptothecin colloidal dispersion","Aminolevulinic Acid","Aminosyn II","Amlodipine 5mg","AMN107","AMN107, STI571","AMN107- NILOTINIB","Amrubicin","ANG1005","Anlotinib","Anlotinib and irinotecan combined with temozolomide","anlotinib and toripalimab","Anlotinib Hydrochloride","Anlotinib hydrochloride capsule","Anlotinib+ Liposomal Doxorubicin","ANP Therapy","Anrotinib hydrochloride combined with adriamycin","Anti PD-1\/L1","anti-CD20 (Rituximab)","Anti-CTLA4 (monoclonal antibody MDX-010)","Anti-PD-1 monoclonal antibody","Anti-PD-L1 antibody atezolizumab","Anti-seizure prophylaxis","anti-thymocyte globulin","Anti-Transforming Growth Factor-beta (GC 1008)","Antiandrogen Therapy","antibody ch14.18","Anticonvulsant Agent","Antineoplaston therapy (Atengenal + Astugenal)","Antiretroviral Combinations","AP1903","Apatinib","Apatinib Combined With Temozolomide and Etoposide Capsules","Apatinib Mesylate","Apatinib mesylate tablets","Apatinib Mesylate, doxorubicin, ifosfamide","Apatinib Mesylate, Pirarubicin, Ifosfamide","Apatinib monotherapy","apatinib plus SHR-1210","Apatinib+IE","Apatinib, Irinotecan, Temozolomide","APG-115","APG-115+Pembrolizumab","APG101","apixaban","Apixaban 5 MG","Aprepitant","APX005M","AR-42","arachides oleum raffinatum","Aranesp (darbepoetin alfa)","Arm A: F16IL2 in combination with paclitaxel","Arm B: Paclitaxel","Armodafinil","Aromatase inhibitor","Aromatase Inhibitor + Palbociclib","Aromatase inhibitor plus GnRH analog","Aromatase Inhibitors","Arotinib hydrochloride capsule placebo","ARQ 197","ARQ 501","arsenic trioxide","ASC40 tablets","Ascorbate","ascorbic acid","AsiDNA","Asoprisnil","ASP3082","ASP4396","Aspirin","Association atezolizumab + BDB001 + RT","Association of berzosertib with gemcitabine","Association of Nivolumab + Relatlimab","Association of pembrolizumab + cabozantinib","Astugenal","ASTX727","At the discretion of the investigator","AT13387 and Imatinib","Atengenal","Atezolizumab","Atezolizumab (1200 mg every three weeks)","Atezolizumab 1200 mg","Atorvastatin","Atorvastatin 20mg","attIL2-T cells","ATX-101","AU-011","Autologous CIK","Autologous Tumor Infiltrating Lymphocytes","Autologous Tumor Infiltrating Lymphocytes LN-145-S1","AUY922","Avapritinib","Avastin","Avastin + Campto \/ radiotherapy + Temodal + Avastin (4 cures)","Avelumab","Avelumab and Gemcitabine","Avelumab and JX-594 and Cyclophosphamide","Avelumab Injection","Axitinib","Axitinib 1 MG","Axitinib 1 MG [Inlyta]","Axitinib Tablets","Axumin, Intravenous Solution","azacitidine","Azacitidine In Combination With Temozolomide","Azacytidine","AZD1390","AZD1775","AZD2014","AZD2171","AZD4547","AZD6244","AZD6244 + Erlotinib","Azedra","Azithromycin Tablets","azurin-derived cell-penetrating peptide p28","B\/F\/TAF","B7-H3 CAR-T","B7-H3CART","Balstilimab","basiliximab","BAY 43-9006","BAY1002670","BAY2666605","BAY2757556 (Larotrectinib, Vitrakvi)","BAY73-4506 (Regorafenib, Stivarga)","BAY806946","BBI-825","BBI503","BCD-263","BDTX-1535","becatecarin","beclomethasone dipropionate","Belinostat","Belinostat, Carboplatin, Paclitaxel","Belvarafenib","Belzupacap Sarotalocan","Bendamustin","Bendamustine","Berubicin","Berubicin Hydrochloride","Berzosertib","Best supportive care","Betamethasone sodium phosphate\/betamethasone acetate (Celestone\u00ae Soluspan\u00ae), 30 mg IM once a day for four days","Bevacizumab","Bevacizumab (Avastin)","bevacizumab + octreotide LAR + capecitabine","Bevacizumab \/ Irinotecan","bevacizumab and CPT-11 and Carboplatin","Bevacizumab Injection","Bevacizumab with chemo","Bevacizumab Zirconium Zr-89","bevacizumab [Avastin]","Bevacizumab, Gemcitabine, Docetaxel and Valproic Acid","Bevacizumab, Irinotecan and Temozolomide","Bevacizumab-IRDye800CW","Bevacizumab\uff0cIrinotecan and Re-radiotherapy","Bexarotene","BEZ235","BEZ235 (Stage 1)","Bezuclastinib in combination with sunitinib","BGG492","BGJ398","BI 1701963","BI 2536","BI 3011441","BI 764532","BI 764532, formulation 1","BI 764532, formulation 2","BI 907828","BIBF1120","BIIB021","BIM 23A760","BIND-014 (Docetaxel Nanoparticles for Injectable Suspension)","Binimetinib","Binimetinib Oral Tablet [Mektovi]","Binimetinib Pill","Bintrafusp alfa","Bintrafusp alfa \/ M7824","Bis-Chloroethyl-Nitroso-Urea (BCNU) withTemozolomide","BKM120","BKM120 Combined with Vemurafenib (PLX4032)","Bleomycin sulfate","BLZ-100","BMS-986205","BMS-986466","bortezomib","Bosutinib","Botensilimab","BR-UPS 5 mg tablet, Inisia 5 mg tablet","BRAF inhibitor dabrafenib and MEK inhibitor trametinib","BRD4 Inhibitor PLX2853","Brigimadlin","Brigimadlin (BI 907828)","brivanib","brostallicin","bryostatin 1","BSI-201 (Iniparib)","BTX-A51","BUMEL","Buparlisib","Bupivacain","Bupivacaine","Bupivacaine liposome","Busulfan","Busulfan - Fludarabine - TBI","Busulfan, Melphalan","buthionine sulfoximine","BVD-523","BYL719","C134 Re-Administration","CA-4948","Cabazitaxel","Cabozantinib","Cabozantinib (XL184) 140 mg","Cabozantinib (XL184) 60 mg","Cabozantinib S-malate","cabozantinib-s-malate","cadonilimab","Caffeine","Calcium Folinate","Camonsertib","Camptosar\u00ae","Camrelizumab","Camrelizumab and Apatinib","Camrelizumab and Bevacizumab","Camrelizumab Combined With Apatinib","Camrelizumab in Combination With Neoadjuvant Chemotherapy","camrelizumab+apatinib","camrelizumab+apatinib+TMZ","Camrelizumab,","Camsirubicin","CAN008","Candonilimab","capecitabine","Capecitabine Oral Product","Capecitabine, Dacarbazine","capecitabine, imatinib mesylate","Capecitabine, Temozolomide","Capmatinib","Carbetocin","Carboplatin","Carboplatin + etoposide","Carboplatin Injection","carboplatin, pemetrexed, docetaxel","carboplatin, pemetrexed, docetaxel, paclitaxel","Cardunilizumab","Carfilzomib","carmustine","caspofungin acetate","CAV\/IE alternate chemotherapy","Cavrotolimod","CB-103","CB-5083","CB-839","CB-Cabo","CB-Erl","CBD","CBE","CBL0137","CBT-1\u00ae","CCNU","CD40 Ligand","CDB-2914","CDDP","CDX-110 with GM-CSF","CDX-1127","Cediranib","Cediranib Maleate","Cefazolin","cefepime hydrochloride","cefixime","Cefpodoxime","Celebrex","celecoxib","celecoxib\/placebo","Cemiplimab","Cemiplimab-Rwlc","Ceralasertib","Cerebraca wafer","Ceritinib","CETEG","Cetuximab","Cetuximab-IRDye 800CW","CFT8634","CGT9486","CGT9486 plus sunitinib","Ch14.18","Ch14.18 Monoclonal Antibody","Ch14.18\/CHO","Checkpoint Blockade, Immune","Chemoradiotherapy Temozolomide","Chemotherapeutic Agent","Chemotherapeutic Combinations","chemotherapies recommended in france","Chemotherapy","Chemotherapy (carboplatin, etoposide, thiotepa)","Chemotherapy (gemcitabine & docetaxel) plus BIO-11006","Chemotherapy + Valproate","Chemotherapy 1","Chemotherapy 2","Chemotherapy AI","Chemotherapy as needed by the patient\u00b4s tumor and stage","Chemotherapy drug","Chemotherapy Drugs","chemotherapy in combination with Endostar","Chemotherapy with Temodar.","CHF6467","Chiauranib","chidamide and toripalimab","CHPP of Cisplatin","cidofovir","cilengitide","Cimetidine","Cisplatin","Cisplatin for Injection","Cisplatin liposomal","Cisplatin Plus Temozolomide","Cisplatin-5FU-Afatinib","Cisplatin\/Carboplatin","cisplatinum and everolimus","Clomiphene Citrate","CLR 131","Clyclophosphamide","CM082 plus JS001","CMF regimen","CMP-001","COB-2914","Cobimetinib","Cohort 1 anti-OX40","Cohort 2 anti-OX40","Cohort 3 anti-OX40","Cohort A: varlilumab & ipilimumab; Cohort B: varlilumab, ipilimumab, CDX-1401 & poly-ICLC","Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus (MPS)","combination of Avelumab and Cabozantinib","Combination of GEN0101 and Pembrolizmub","Combination of MK3475 with Metronomic CP","Combination of MK3475 with Metronomic CP and G100","Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2","combination of TLC D-99 and Ifosfamide","Combination of trabectedin with durvalumab","Combination of Tumor-infiltrating lymphocyte transfer with ANV419","Combination of two marketed drugs (irinotecan and cisplatin)","Combination of varlilumab and ipilimumab","Combination of varlilumab and nivolumab","combinations of up to 3 FDA approved drugs from a panel of compounds","Combined administration of irinotecan and rapamycin","Combined chemotherapy with trabectedin followed by irinotecan","Combined Oral Contraceptive Pill","Combined oral contraceptives","Combined T3 and Methimazole treatment","Compound 451238","Consolidation BuMel","Continuation of boosted PI","continuous 5 fluouracil infusion plus long-acting octreotide","continuous oral cyclophosphamide and methotrexate","Continuous PD-1 inhibitor therapy","Conventional induction chemotherapy","Copanlisib","Copper Gluconate","Corticotropin-Releasing Hormone","Coxsackievirus A21","CP-675,206","CP-751,871","CP4071","CPG 7909 Injection","CPI 613","CPI-0610","CPI-613 + Hydroxychloroquine","CR011-vcMMAE","CRD3874","Crenolanib","Crenolanib besylate (CP-868,596-26), Dose: 140mg BID","Crizanlizumab-Tmca 10 MG\/1 ML Intravenous Solution [ADAKVEO]","Crizotinib","Crizotinib (PF-02341066)","Crystalloid based prime solution","CS3007 (BLU-285)","CTO","CTO alone","CTO and Bevacizumab","CTO and Temodar\u00ae","CTO, Temodar\u00ae, Radiation therapy","CUDC-907","CX 4945","CX-072","CYC","Cycles N5 and N6","Cycles N8, N5 and N6","Cyclophosphamide","Cyclophosphamide (low dose)","Cyclophosphamide + Busilvex","Cyclophosphamide + Fludarabine Lymphodepletive Conditioning","Cyclophosphamide and Fludarabine","Cyclophosphamide and JX-594","Cyclophosphamide and JX-594 dose escalation","Cyclophosphamide and Sirolimus","Cyclophosphamide Oral Product","Cyclophosphamide Pill","cyclophosphamide, adriamycin, vincristine\uff0cIfosfamide\uff0cetoposide","Cyclophosphamide, Topotecan, and Bevacizumab","cyclophosphamide, vincristine, topotecan ,allogeneic NK cells & 3F8","Cyclosporin","cyclosporine","Cyclosporine A","CyPep-1","cyproheptadine hydrochloride","Cyproheptadine Hydrochloride 4 MG","cytarabine","Cytoxan","D2C7-IT","D2C7-IT (4613.2 ng\/mL via convection-enhanced delivery)","D2C7-IT (6920 ng\/mL via convection-enhanced delivery)","D3S-001","Dabigatran 150 Mg Oral Capsule","Dabrafenib","Dabrafenib 150 mg","dabrafenib 150 mg orally twice a day","Dabrafenib and trametinib (combination)","Dabrafenib Mesylate","dacarbazine","Dacarbazine (DTIC)","dacarbazine (DTIC), Trofosfamide, Etoricoxib, Pioglitazone, Temsirolimus","Dacarbazine and bortezomib","Dacarbazine of 850 mg\/m^2, or 1,000 mg\/m^2, or 1,200 mg\/m^2 IV","dacarbazine plus Endostar (Experimental group)","dacarbazine plus placebo (control group)","Dacarbazine, temozolomide or talimogene laherparepvec","Dactinomycin","dalotuzumab","Dalteparin","Daratumumab SC","Darbepoetin alfa","darinaparsin","Daromun","Darovasertib","Dasatinib","Daunorubicin (liposomal)","daunorubicin hydrochloride","DAY101","DCB-BO1301","DCC-2618","DCC-3014","DCC-3116","DCR-MYC","Debio 0123","Debio 1347","Debio 4126","Decitabine","Decitabine and Cedazuridine","Decitabine and Hiltonol","Defactinib Hydrochloride","deferasirox","Definity Suspension for Injection","deligoparin","DeltaRex-G","dendritic cell-gp100-MART-1 antigen vaccine","Denileukin diftitox","Denosumab","Denosumab (Cohort A)","Denosumab 120 MG\/1.7 ML Subcutaneous Solution [XGEVA]","depletion of regulatory T cells","Desflurane","Desogestrel","Dexamethasone","Dexamethasone acetate","dexamethasone and cyclophosphamide","dexamethasone and rituximab","Dexamethasone intravitreal implant","Dexmedetomidine","Dexrazoxane","dexrazoxane hydrochloride","DF6215","DFMO","DHEA","Diagnostic work up","Diazoxide","Dichloroacetate (DCA)","Didanosine","Dienogest","Difluoromethylornithine","Difluoromethylornithine (DFMO)","digoxin","dinaciclib","Dinutuximab","Dinutuximab Beta","Dinutuximab Beta, Zoledronic acid, Interleukin-2","Dinutuximab. Immunotherapy","Diphenhydramine","disaccharide tripeptide glycerol dipalmitoyl","Disulfiram","Disulfiram (DSF)","Disulfiram\/Copper","DNX-2401","Docetaxel","Docetaxel (Taxotere)","docetaxel + trastuzumab sc + pertuzumab","Docetaxel injection","Docetaxel+lobaplatin","dolastatin 10","Domatinostat","domatinostat in combination with avelumab","Donepezil","donepezil hydrochloride","Donor NK Cell Infusion","Dose Escalation of Durvalumab and Trabectedin","Dose Expansion of Durvalumab and Trabectedin","Dose-Intensified TMZ","Dostarlimab (TSR-042) (singly)","Dostarlimab (TSR-042) and TSR-022 (combination)","Dostarlimab in Combination Antiretroviral Therapy","dovitinib","Dovitinib (TKI258)","dovitinib lactate","dovitinib plus imatinib","Doxil","Doxorubicin","Doxorubicin HCl","Doxorubicin HCl liposomal injection","doxorubicin HCl liposome","Doxorubicin Hydrochloride","Doxorubicin hydrochloride (DOX)","Doxorubicin hydrochloride (liposomal)","Doxorubicin Hydrochloride Injection","Doxorubicin Hydrochloride Liposome+Irinotecan","doxorubicin in combination with palifosfamide-tris","doxorubicin in combination with placebo","doxorubicin with AGEN1884 and AGEN2034","Doxorubicin+cisplatin+ifosfamide","Doxorubicin+cisplatin+ifosfamide+methotrexate","Doxorubicin+Ifosfamide+Anlotinib(AI+A)","Doxorubicin, Cisplatin","Doxorubicin, Cisplatin, Methotrexate","doxorubicin, cytoxan","doxorubicin, ifosfamide","doxorubicin, ifosfamide, cisplatin","Doxorubicin, Methotrexate","doxorubicin\u3001cisplatin\u3001methotrexate\u3001ifosfamide","Doxycycline","Doxycycline Injection [Doxy]","DPPG2-TSL-DOX","DPX-E7 vaccine","Drosophila-peptide pulsed Melanoma-reactive autologous CD8+ PBL","Drug (including placebo)","Drug therapy","Drug: Everolimus","Drug\uff1aLM-102","DS-1001b","DS-6157a","DT01","DTIC","DTIC alone; then Genasense followed by DTIC","duloxetine","Durvalumab","Durvalumab 50 MG\/1 ML Intravenous Solution [IMFINZI]","Durvalumab and Chemotherapy(oxaliplatin and capecitabine)","Durvalumab with etoposide and Carboplatin\/Cisplatin","Durvalumab+doxorubicin cobination","Durvalumab, pazopanib","Duvelisib","Dydrogesterone M ( case 1 )","Dydrogesterone M ( case 2 )","DYP688","E2\/NETA","E2\/NETA placebo","E6201","E7 Peptide","E7016","E7389","Edoxaban 60 MG","EF-1 Peptide","EF-2 Peptide","EF5","efatutazone","Efavirenz, TDF, and 3TC","efavirenz\/emtricitabine\/tenofovir disoproxil fumarate","Eflornithine","eflornithine HCl","Eflornithine Hydrochloride","EGFR\/EGFRvIII Inhibitor WSD0922-FU","EIA chemotherapy","Elagolix","Elemene","ELIGARD","Elimusertib","eltrombopag","Elvitegravir, Cobicistat, TAF, FTC","Emactuzumab","Empegfilgrastim","EN3835","Enalapril","Enasidenib","Encorafenib","Encorafenib + Binimetinib","Encorafenib Pill","Endostar","Endostar (recombinant human endostatin injection)","Endostatin","enfortumab vedotin","ENMD-2076","Enoblituzumab","Enoxaparin","Ensartinib","Entacapone","entinostat","Entrectinib","ENV-101 (taladegib)","Envafolimab","Envafolimab combined with recombinant human endostatin and first-line chemotherapy","Enzastaurin","Enzastaurin (LY317615)","enzastaurin hydrochloride","Enzyme-inducing antiepileptic drugs (EIAED)","Epacadostat","Epinephrine","Epirubicin","epirubicin 60 mg\/m2\/day (days 1, 2) and ifosfamide 3 g\/m2\/day (days 1, 2, 3)","epirubicin hydrochloride","ERAS-007","ERAS-601","ERC1671","Erdafitinib","Erenumab-Aooe","Erenumab-Aooe Matching Placebo","Eribulin","Eribulin mesilate","Eribulin mesylate","Eribulin mesylate 1.4 mg\/m^2 intravenous","Eribulin, gemcitabine","Erlotinib","erlotinib hydrochloride","Erythrocyte based prime solution","Erythromycin","Escitalopram","Esomeprazole 40mg before","Esomeprazole 40mg concomitantly","Estradiol","Estradiol steroid infusion","Estradiol\/norethindrone acetate","Estradiol\/Norethindrone acetate (E2\/NETA)","Estradiol\/norethindrone acetate placebo","Estrogen Product","Etanercept","ETH-155008","ethanol","Etirinotecan pegol","ETO","Etoposide","Etoposide (VP-16)","etoposide 150 mg\/m2\/day (days 1, 2, 3) and ifosfamide 3g\/m2\/day (days 1, 2, 3)","Etoposide Injection","Etoposide Phosphate","etoposide plus carboplatin","Etoposide Plus Cisplatin","Etoposide, Carboplatin","Etoposide, carboplatin, melphalan, cisplatin, thiotepa","Etoposide, Cisplatin","Etoposide, Ifosfamide, Methotrexate","Etrumadenant","Eutectic Mixture of Local Anesthetics","EVAX-01-CAF09b","Everolimus","Everolimus (Afinitor\u00ae)","Everolimus (RAD001)","Everolimus (RAD001), Afinitor\u00ae","Everolimus 10 mg\/day","Everolimus 2.5 mg\/day","everolimus and letrozole","Everolimus followed by Pasireotide LAR + Everolimus","Everolimus Placebo","Everolimus plus Octreotide LAR plus Metformin","EVT801","EVX-01","EVX-02A","EVX-02A OR EVX-02B","EVX-02B","exatecan mesylate","Exemestane","Exenatide","Experimental arm: Trabectedin + Olaparib","Extracted capsules 13-CRA","Ezabenlimab","F-18 16 Alpha-Fluoroestradiol","F-18 Fluorodeoxyglucose","F-18 Fluoroethyltyrosine (FET)","F-18 RGD-K5","F16IL2 in combination with paclitaxel","FACT Complex-targeting Curaxin CBL0137","False injection","fam-trastuzumab deruxtecan-nxki","Famitinib","Famitinib capsules","Famotidine","FAZ053","fb-PMT","fenofibrate","Fenofibric acid","fenretinide","fenretinide lipid matrix","Fenretinide Lym-X-Sorb Oral Powder","Fenretinide\/LXS Oral Powder","Fentanyl sublingual spray","Feraheme","Ferric Carboxymaltose","Ferrous sulphate","Ferumoxtran-10 (Combidex)","Ferumoxytol","Ferumoxytol Non-Stoichiometric Magnetite","FF-10850 Topotecan Liposome Injection","FGFR Inhibitor, IDH1 Inhibitor, HER2 Inhibitor, PARP Inhibitor, BRAF Inhibitor, MEK Inhibitor, ICIs, EGFR-TKIs, NTRK-TKI, and et. al.","FHD-286","FHD-609","Fibrin Sealant","Filgrastim","Filgrastim, peg-filgrastim","Fimepinostat","first-line chemotherapy","floxuridine","FLT PET","flt3 ligand","Fluciclatide Injection - (AH111585 (F18))","Fluciclitite, PET imaging, and Bevacizumab","Fluciclovine PET guided Radiotherapy","Fludara","Fludarabina","Fludarabine","Fludarabine + Cyclophosphamide combination","fludarabine phosphate","fluorescein","Fluorescein Sodium","Fluorescein Sodium Injection","Fluoresc\u00e9ine Sodique Faure","fluorescent cRGDY-PEG-Cy5.5-C dots","fluorescent Peptide","Fluorine F 18 Fluorodopa","fluorine F 18 fluorothymidine","Fluorine-18-L-dihydroxyphenylalanine","Fluorodopa F 18","Fluorothymidine F-18","fluorouracil","Fluzoparib","Fluzoparib+ Dalpiciclib","FLX475","FMT Protocol","FN-1501","FOLFIRI","FOLFIRI (5-Fluorouracil, Folinic acid, Irinotecan)","Folfiri-bevacizumab","Folfirinox + cetuximab","FOLFOX","Folinic Acid","Fosaprepitant","Fosaprepitant Dimeglumine","fosbretabulin","fosbretabulin tromethamine","Fotemustine","Fotemustine + Vemurafenib","Fotemustine and Ipilimumab","Fruquintinib","FT-2102","Fulvestrant","Furosemide Injection","FZ-AD005","G-CSF","G-CSF (granulocyte-colony stimulating factor)","G207","Ga 68 PSMA-11","Ga-68-DOTA-TOC","Ga-68-PSMA-11 PET\/CT","Gabapentin","Gadobenate Dimeglumine","Gadobutrol","Gadolinium","Gadolinium DTPA","Gadolinium-Chelate","Gallium Dotatate","Gallium Ga 68 FAPi-46","Gallium Ga 68-DOTATATE","Gallium Ga 68-Edotreotide","gallium nitrate","Gallium-68 DOTATOC","Galunisertib","Gamma 1b potential expansion","gamma secretase inhibitor PF-03084014","Gamma-Secretase Inhibitor RO4929097","gamma-secretase\/Notch signalling pathway inhibitor RO4929097","ganciclovir","ganetespib","Ganitumab","Ganoderma lucidum","Gantenerumab","GC1118","GCSF","GD regimen","GD2 CAR T cells","GDC-0084","GDC-6036","GEC255 tablets","gefitinib","Gefitinib, Irinotecan, Cycophosphamide, Doxorubicin, Etoposide, Cisplatin, Topotecan, Carboplatin, Melphalan, 13-cis retinoic acid","Gefitnib","Gemcitabine","Gemcitabine (Gemzar\u00ae), Oxaliplatin (Eloxatin\u00ae)","gemcitabine + docetaxel","Gemcitabine + Rapamycin","Gemcitabine + Trabectedin","gemcitabine 1800 mg\/m2 (day 1) and dacarbazine 500 mg\/m2 (day 1)","gemcitabine 900 mg\/m2 (days 1 and 8) and docetaxel 75 mg\/m2 (day 8)","Gemcitabine and Cisplatin","Gemcitabine and Docetaxel","Gemcitabine and Pazopanib","gemcitabine hydrochloride","Gemcitabine Hydrochloride Injection","Gemcitabine plus PM060184","Gemcitabine plus rapamycin","Gemcitabine+Cisplatin(GP); Cyclophosphamide+Etoposide+Cisplatin(CEP)","Gemcitabine+lobaplatin","Gemcitabine, Docetaxel","Gemcitabine, Docetaxel and Bevacizumab","gemcitabine, docetaxel, doxorubicin","Gemcitabine, Oxaliplatin, Capecitabine,","Genasense followed by DTIC; then DTIC alone","Genasense\u00ae (G3139, oblimersen sodium)","Gene evolution and molecular response under Bevacizumab treatment","Generic HAART Triomune : d4T, 3TC, NVP","Generic HAART Triomune : d4T, 3TC, NVP and chemotherapy ABV","Genistein","Gentamicin","Gentamicins","GH35 Tablet","GIM-531","Gimatecan\u00ae (ST 1481)","Glasdegib","Gleevec","Glembatumumab Vedotin","Gliadel Wafer","Gliadel wafers in combination with O6-benzylguanine","Gliolan\u00ae","Glivec","Glivec 100mg film coated tablet","Glivec film-coated tablet 100 mg, 4 Tablets","Glucarpidase","Glufosfamide","glutamine","GM-CSF","GM-CSF (granulocyte-macrophage colony-stimulating factor)","GnRH analogue","GnRH analogue (Zoladex)","GnRH antagonist","GnRH antagonist-Cetrorelix","GNRH-A Triptorelin","GnRHa","Golvatinib","Gonadotropins","Good responder group adjuvant chemotherapy","Goserelin","Goserelin + Aromatase Inhibitor + Palbociclib","gp100 antigen","gp100:209-217 (210M)","GPX-150 for Injection","Granisetron","Granisetron hydrochloride","Group AD Anti-PD + Antidepressant","Group R Rasagiline","Group R+AD Rasagiline + Antidepressant","GS-9716","GSK1120212","GSK2118436","GSK3377794","Guadecitabine","GVP","GX-I7","HA121-28 tablets","HAIC\u3001Bevacizumab\u3001Camrelizumab","halofuginone hydrobromide","HBI-8000 in combination with nivolumab","HDM201","Hematopoietic Factor","Heparin","Herceptin","HH2853 Tablets","HIF-2alpha Inhibitor PT2385","high dose long-acting octreotide","High Dose Methotrexate","high-dose chemotherapy","high-dose ifosfamide 14 g\/m2, given in in 14 days","High-dose methotrexate infusion duration","high-dose NGR-hTNF","High-dose recombinant interferon a-2B","High-Risk Therapy","Highly selective FGFR1-3 inhibitor","Hiltonol","HLX208","HM10460A (135 \u03bcg\/kg)","HM10460A (270 \u03bcg\/kg)","HM10460A (45 \u03bcg\/kg)","HMPL-306","Horse Antithymocyte Globulin","HPPH","HQP1351","HS-20093","human chorionic gonadotropin","Human Chorionic Gonadotropin (hCG)","human interferon-\u03b1","HX008 + TACE","Hyaluronidase-zzxf\/Pertuzumab\/Trastuzumab","Hydrocortisone","Hydrogen","Hydromorphone","Hydroxychloroquine","hydroxychloroquine (HCQ)","Hydroxychloroquine Sulfate","Hydroxyurea","Hydroxyurea capsules","Hyperbaric oxygen","Hyperpolarized 13CPyruvate","Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG)","Hyperpolarized Carbon C 13 Pyruvate","Hyperthermic Intraperitoneal Chemotherapy","Hypomethylating agents","I-131-CLR1404","IBI188","IBI308","IBI310+IBI308","Ibrutinib","Icapamespib","ICG","Icotinib","idarubicin","Idasanutlin","IDE196","IDH1R132H peptide vaccine","IE","IFN-alpha with retinoic acid","IFO","Ifosfamide","ifosfamide and doxorubicin vs gemcitabine and docetaxel","ifosfamide and etoposide","ifosfamide and mesna","Ifosfamide chemotherapy (AI)","Ifosfamide or dacarbazine","Ifosfamide, Carboplatin, Doxorubicin","Ifosfamide, oncovin, actinomycine D, epirubicine, carboplatinum, etoposide","Ifosfamide-based chemotherapy (AI)","IGF-1R\/AS ODN","IK-930","IL-2","IL-2 and Nivolumab","IL-2 i.v.","IL-2 s.c.","IL-4","IL13-PE38QQR","IM862","imatinib","Imatinib (Glivec)","imatinib (STI571)","Imatinib 400 MG","Imatinib 600mg\/day (Glevec is the brand name for imatinib)","Imatinib 800mg\/day (Glevec is the brand name for imatinib)","Imatinib escalation","Imatinib maintenance","Imatinib mesilate","imatinib mesylate","Imatinib Mesylate (Gleevec)","Imatinib Mesylate (Gleevec\u00ae; STI571; NSC #716051)","Imatinib mesylate (Glivec)","Imatinib mesylate tablet 400 mg, 1 Tablet","Imatinib Mesylate Tablets, 400 mg","Imatinib mesylate, Cyclophosphamide (Dosing level 1 )","Imatinib mesylate, Cyclophosphamide (Dosing level 2)","Imatinib mesylate, Cyclophosphamide (Dosing level 3)","Imatinib tablets","Imatinib treatment","IMC-12","IMCgp100","Imetelstat","Imetelstat Sodium","Imiquimod","Imiquimod Cream","Imiquimod cream + surgery","IMM-1-104","IMM-1-104 + modified FOLFIRINOX (Treatment Group C)","IMM-1-104 + modified Gemcitabine\/nab-Paclitaxel (Treatment Group B)","IMM-1-104 Monotherapy (Treatment Group A)","immune-checkpoint inhibitors therapies","Immunotherapeutic Agent","Immunotherapeutic Combination Product CMB305","Immunotherapy","IMP321 (eftilagimod alpha)","Inavolisib","INBRX-109","INC280","INCB057643","INCB059872","INCMGA00012","incyclinide","indinavir","Indinavir in association with Vinblastina +\/- Bleomicina","indinavir sulfate","Indium-111 pentetreotide","Individualized therapy","indocyanine green","Indocyanine Green Solution","Indocyanine green solution administered at 2.0mg\/kg.","Indocyanine green solution administered at 2.5mg\/kg.","Induction Chemotherapy","Inert Capsule","Infigratinib","Infliximab","infusion of melphalan and dactinomycin","Infusion with ipilimumab 3 mg\/kg q3wks","Infusion with nivolumab 1 mg\/kg q3wks","Inhaled Lipid Cisplatin (ILC)","INNO-206","INT230-6","Intensified chemotherapy","INTERCOAT administration","Interferon alfa-2a","Interferon alfa-2b","Interferon alfa-n1","Interferon Alpha","interferon alpha 2b","Interferon alpha-2b","Interferon beta-1b","Interferon gamma 1b in combination","Interferon-alpha","Interferon-alpha-2b","Interferon-gamma","interleukin-12","Interleukin-2","Interleukin-2 (Proleukin)","Interleukin-2\/Zidovudine (AZT)","Interleukin-4","Intermediate-Risk Therapy","Intermittent PD-1 inhibitor therapy","interruption of Glivec\u00ae","Intra-abdominal Lidocaine","Intra-lesional injection of nivolumab","Intranasal Modified Temozolomide","Intrathecal Chemotherapy","intrathecal nivolumab and intrathecal ipilimumab","Intratumoral injections of L19IL2","Intravenous (IV) Chemotherapy (Regimen 1)","intravenous fluorescein sodium","Intravenous injection of 177Lu-octreotate","Intravenous Lidocaine","Intravenous placebo\/Intravenous placebo","intraventricular etoposide","Investigator's Choice of Chemotherapy","Investigator's Choice Treatment (Darcabazine, Pazopanib, Gemcitabine + Docetaxel, Doxorubicin, Ifosfamide)","Investigators Choice","IOA-244","Iobenguane I 123 Injection","iodine I 131 metaiodobenzylguanidine","Iodine I 131 MOAB 8H9","ION363","iopromide","IP-001","Ipatasertib","IPI-504","IPI-549 (eganelisib)","IPI-926","ipilimumab","Ipilimumab (1mg\/kg)","Ipilimumab 1 mg\/kg","Ipilimumab 5 MG\/ML Injection [Yervoy]","ipilimumab and dabrafenib","Ipilimumab and Fotemustine","Ipilimumab and nivolumab","Ipilimumab at 3 mg\/kg dose","Ipilimumab IT","Ipilimumab IV","Ipilumimab","Irinotecan","Irinotecan (Camptosar), Gefitinib (Iressa)","Irinotecan (Camptosar, CPT-11)","Irinotecan (Irinotecan Cell pharm\u00ae)","Irinotecan and Bortezomib","irinotecan and temozolomide","irinotecan and temozolomide and naxitamab and GM CSF","irinotecan hydrochloride","Irinotecan Hydrochloride Liposome Injection","Irinotecan&Temsirolimus:Arm 1, Level 2","Irinotecan&Temsirolimus:Arm 2, Level 1","Irinotecan&Temsirolimus:Arm1, Level 1","irinotecan, temozolomide, and bevacizumab incorporated into an existing schedule of high dose alkylator","Iron","Iscador*P","isoflurane, sevoflurane or desflurane","isolated limb perfusion","isolated perfusion","Isophosphamide","Isosulfan blue (ISB)","Isotretinoin","Isotretinoin (13-cis-retinoic acid)","ispinesib","Itacitinib","ITI-3000","Itraconazole","IV Acetaminophen","IV Bolus Etoposide","IV Chemotherapy (Regimen 1)","IV Chemotherapy (Regimen 2)","IV Ibuprofen","IV tranexamic acid","Ivosidenib","Ivosidenib 500mg","ixabepilone","Ixazomib","Ixazomib Citrate","JS001+Imatinib mesylate","JTX-8064","KB-0742","KCP-330","Keratinocyte Growth Factor","Ketoconazole","Ketorolac","Keytruda","KEYTRUDA\u00ae","KLH-2109","KRT-232","KSH01 injection","KU-0059436 (AZD2281)(PARP inhibitor)","KW-2871","L-carnitine","L-MTP-PE","L19IL2","L19IL2 - Ph I","L19IL2 at RD - Ph II","L19IL2+L19TNF","L19IL2\/L19TNF","L19TNF","L19TNF\u03b1","L9-NC","Lacosamide","LAM561","Lamivudine","Lanreotide","Lanreotide (Autogel formulation)","Lanreotide (Autogel formulation) and Temozolomide","Lanreotide and Metformin","Lanreotide autogel","lanreotide Autogel (somatostatin analogue)","Lanreotide Autogel 120 mg","Lansoprazole","Lapatinib","Lapatinib and ixempra","Lapatinib Ditosylate","LAR Lanreotide","LAR Octreotide","laromustine","Larotrectinib","Larotrectinib Sulfate","larotrectinib(Vitrakvi, BAY2757556)","LB-100 plus Doxorrubicin","LBH589","LBH589 (Panobinostat\u00ae)","LBL-007","LBL-024 for Injection","LDE225","LDN","LEE011","Leflunomide 20 mg","Lenalidomide","Lenvatinib","Lenvatinib mesylate capsule","Lenvatinib Oral Product","Lenvatinib, Pembrolizumab","LEQ506","Lerapolturev","lestaurtinib","letetresgene autoleucel","Letrozole","Letrozole (aromatase inhibitor)","Leucovorin","leucovorin calcium","leuprolide","Leuprolide acetate","leuprolide acetate for depot suspension","Leuprorelin","Leuprorelin (GC)","Leuprorelin (GF)","Leuprorelin Placebo","levetiracetam","Levonorgestrel IUS","Lexatumumab alone","Lexatumumab in combination","LFA102","LGX818","Lidocaine","Lidocaine hydrochloride ophthalmic gel 3.5%","Lidocaine per-embolization","Lidocaine post-embolization","Light-activated AU-011","Linsitinib","Liothyronine","Lipegfilgrastim","Lipiodol\u00ae Ultra Fluid with surgical glues","Liporaxel","Liposomal Annamycin (L-Annamycin)","Liposomal Bupivacaine","Liposomal cytarabine","liposomal daunorubicin citrate","Liposomal Doxorubicin","Liposomal Doxorubicin (Doxil)","Liposomal Irinotecan","liposomal vincristine sulfate","Liposome doxorubicin","Liquid 13-Cis Retinoic Acid","Lithium Carbonate","LMP1\/2 CTLs (Group A)","LMP1\/2 CTLs (Group B)","lobradimil","Local Standard of Care","lomustine","lomustine and procarbazine","Lomustine Chemotherapy","Lomustine Pill","Lomustine\/Vincristine\/Procarbazine","Lonafarnib","long-acting octreotide","long-acting Octreotide.","Loperamide","Lopinavir\/ritonavir plus Emtricitabine\/Tenofovir versus Efavirenz plus Emtricitabine\/Tenofovir","Lorlatinib","Losartan","lovastatin","low-dose NGR-hTNF","Low-Risk Therapy","LOXO-292","LP-284","LS301","LTC004","LTC004 in Combination With Cyclophosphamide and Fludarabine","Lu-177 DOTA-TATE","Lu-177 DOTATATE (Lutathera\u00ae)","Lu-177 labeled 6A10-Fab-fragments","Lu-177-DOTATATE","Lu-177-ITG-PSMA-1","Lu-PRRT","Luckyvec 400mg film coated tablet","Lucron Depot","LUM015","Lupron Depot","Lurbinectedin","lurbinectedin (PM01183)","Lutathera","Lutetium (177Lu) Oxodotreotide Injection\uff1blong-acting Octreotide","Lutetium Lu 177 Dotatate","Lutetium-177 Octreotate","Lutetium[177Lu] Oxodotreotide Injection","LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide","LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide","LVGN3616 + LVGN6051 + LVGN7409 + Nab-Paclitaxel","LVGN3616 + LVGN6051 + Nab-Paclitaxel","LXS196","LXS196 and HDM201","LY2228820","LY2880070","LY3295668 Erbumine","LY573636-sodium","Lymphodepletion Chemotherapy","Lyso-thermosensitive liposomal doxorubicin","M6620","M7824","M7824+M7824","MAGE-12 peptide vaccine","Magnesium-Dexmedetomidine","Magrolimab","Maintenance","Maintenance chemotherapy","maintenance chemotherapy (vincristin, cisplatin and CCNU)","MAK683","Mannitol","MAPI chemotherapy","Maraviroc","Maraviroc along with an optimized background antiretroviral drug regimen","Marizomib","Marqibo","Marqibo\u00ae (vincristine sulfate liposomes injection)","MART-1 antigen","masitinib","Matched placebo","Matching Placebo","Matching Placebo (Gantenerumab)","Matching Placebo (Solanezumab)","MBG453","MCS110","MDM2 Inhibitor KRT-232","Mebendazole","Mechlorethamine Hydrochloride","MEDI4736","Medical Therapy","Medroxyprogesterone Acetate 150 MG\/ML","megestrol acetate","MEK 162 therapy or molecularly targeted therapy","MEK162","Melatonin","Melatonin Replacement Therapy","Meloxicam 7.5mg daily for 8 weeks","Melphalan","Melphalan chemosaturation via percutaneous hepatic perfusion","Melphalan Hydrochloride","Melphalan Injection","MESNA","Metaiodobenzylguanidine (MIBG)","Metformin","Metformin Group","Metformin Hydrochloride","Methimazole","Methionine","Methotrexate","Methotrexate,Calcium folinate","Methoxyamine","methylprednisolone","Methylsulfonic apatinib","Metronomic CPA","Metronomic Cyclophosphamide","metronomic therapy","MGCD516","MGD013","Mibefradil with Radiation","Midazolam","Mifamurtide","Mifamurtide (L-MTP-PE)","Mifamurtide arm","Mifegyne","Mifepristone","Mifepristone tablets","mifepristone vaginal tablets","Minocycline","Minocycline with chemoradiation (temozolomide and radiation therapy)","Minocycline-EDTA","Mirdametinib","Mirtazapine (Remeron)","Misoprostol","Misoprostol 400 Microgram Oral Tablet","Misoprostol Pfizer Brand","Mithramycin","mitomycin C","Mitoxantrone hydrochloride","Mitoxantrone Hydrochloride Liposome Injection","MK-0646","MK-0752","MK-1084","MK-2206","MK-3475","MLN0128","MLN8237","MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide","MN-001","MN-001 BID","Mocetinostat","Momelotinib (MMB)","Montanide ISA 51","Montanide ISA 51 VG","Montanide ISA-51","MOPP Regimen","MORAb-004","Morphine","motexafin gadolinium","motexafin lutetium","moxifloxacin hydrochloride","MT-3724","MTC-DOX for Injection","MTX110","multi-kinase inhibitors in combination with bevacizumab","Multipeptide plus XS15","Multiple drug microinjection","Muscle Relaxants, Non Depolarizing","MVASI\u00ae (bevacizumab-awwb)","Mycophenolate Mofetil","Myeloid growth factor","N-Acetylcysteine","nab paclitaxel","Nab-Paclitaxel","nab-paclitaxel + gemcitabine","Nab-Rapamycin","nab-sirolimus","nab-sirolimus + bevacizumab","nab-sirolimus + lomustine","nab-sirolimus + marizomib (MRZ)","nab-sirolimus + temozolomide","nab-sirolimus + temozolomide + radiotherapy","Naltrexone","Nanatinostat","nanoliposomal irinotecan","Nanoparticle Albumin-Bound Rapamycin","Naporafenib","Naporafinib","Naproxen Sodium","Narlumosbart","narlumosbartmab plus doxorubicin\u3001cisplatin\u3001methotrexate\u3001ifosfamide","Natalizumab","Navtemadlin","Naxitamab","NB003 tablets","NBE-002","NC 6300","Nelfinavir Mesylate","Nemvaleukin Alfa Intravenous","Nemvaleukin Alfa Intravenous Less Frequent Dosing","Nemvaleukin Alfa Subcutaneous","Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV","NEO100","neoadjuvant chemotherapy","neoadjuvant chemotherapy+SPIONs\/SMF","Neoadjuvant ipilimumab + nivolumab","NeoPep Vaccine1 plus Poly-ICLC","NeoPep Vaccine2 plus Poly-ICLC","Netupitant\/Palonosetron","Neulasta","Neulasta (pegfilgrastim)","Neuradiab in combination with Bevacizumab (Avastin)","NeuVax vaccine","NHS-IL-12","NHS-IL12","NHS-IL12+M7824","Niacin CRT","nicotine","Nifurtimox","Nilotinib","Nilotinib (AMN107)","Nilotinib with Imatinib","Nilotinib, Imatinib","Nilotinib-adriamycin","NiMODipine Injectable Solution","nimotuzumab","Nintedanib","Nintedanib-Placebo","niraparib","Niraparib Tosylate Monohydrate","Nirogacestat","Nirogacestat (Gamma Secretase Inhibitor)","Nirogacestat oral tablet","Nitroprusside","Nitroprusside and phenylephrine","nivolumab","Nivolumab & Tumor Infiltrating Lymphocytes with\/without Interferon-Alpha","Nivolumab + Ipilimumab","Nivolumab 10 MG\/1 ML Intravenous Solution [OPDIVO]","Nivolumab 100 MG\/10 ML [Opdivo]","Nivolumab 240 mg","Nivolumab 240 mg \/ Relatlimab 80 mg in a fixed dose combination","Nivolumab 240 mg IV","Nivolumab 3 mg\/kg","Nivolumab and Entinostat","Nivolumab and IPILIMUMAB","Nivolumab and\/or Ipilimumab","Nivolumab Injectable Product","Nivolumab Injection","Nivolumab IV","Nivolumab IV Soln 100 MG\/10ML","NIZ985","NIZ985 and Spartalizumab","NK510","NKTR-214","no carrier added metaiodobenzylguanidine","NO GnRHa","No Intervention: Observational Cohort","Non-enzyme inducing antiepileptic drugs (NEIAED)","Norepinephrine","norethisterone acetate","normal saline","NOX66","NPC-07 for oral administration","NPC-08","NRX 195183 Soft Gelatin Capsule","Nuvigil\u00ae","NY-ESO-1 TCR\/IL-15 NK","O-(2-[18F]Fluoroethyl)-L-tyrosine, [18F]-FET with PET\/MRI","O-(2[18F]FLUOROETHYL)-L-TYROSINE","O6-benzylguanine","OBE2109 + Add-back","OBE2109 + Placebo Add-back","Obinutuzumab","OBP-301","octreotate","Octreotide","octreotide acetate","Octreotide LAR","Octreotide LAR Depot","ODSH","OKN-007","olaparib","Olaparib 150 MG","Olaratumab","Olaratumab and Trabectedin","omaveloxolone","OMBRABULIN (AVE8062)","omega-3-acid ethyl esters","onapristone","ONC201","ONC206","OncoLAR\u00ae (Registered Trademark)","Oncolytic Virus SDJ001","Oncolytic Virus YD06-1","Ondansetron","One injection of 68Ga-NODAGA-E[c(RGDyK)]2","One injection of 68Ga-NOTA-AE105","Onfekafusp alfa","Ontorpacept (TTI-621)","Opdivo","Opdualag","oprelvekin","Optimized background antiretroviral drug regimen without maraviroc","oral 5-azacitidine in combination with romidepsin","Oral administration of mifepristone 2.5 mg daily for three months","Oral administration of mifepristone 5 mg daily for three months","oral cyclophosphamide","Oral dabrafenib and trametinib","oral drug and oral placebo","oral drug and vaginal placebo","oral isotretinoin","oral masitinib","Oral MRT-2359","Oral repotrectinib (TPX-0005)","Oral sotorasib + IV Panitumumab","Oral Topotecan Hydrochloride","oral tyrosine-kinase inhibitors (TKI) of KIT and PDGFR as per recommendations","ORAL VINORELBINE","Oraxol","OSI-930","OSI-930 and erlotinib","Osimertinib","OST31-164","Other Therapy","OTSA101-DTPA-111In","OTSA101-DTPA-90Y","OTSA101-DTPA-90Y level 1","OTSA101-DTPA-90Y level 2","OTSA101-DTPA-90Y level 3","oxaliplatin","Oxaliplatin + Folinic acid + Fluorouracil","Oxaliplatin + Folinic acid + Fluorouracil + Bevacizumab","Oxaliplatin-based chemotherapy","Oxycodone","Oxytocin","Ozurdex","P1446A-05","PAC-1","Pac-CB","paclitaxel","paclitaxel albumin-stabilized nanoparticle formulation","Paclitaxel Injection","Paclitaxel plus carboplatin","Pacritinib","Palbociclib","Palbociclib 125mg","Palbociclib 200mg","palbociclib isethionate","Palifermin","Palifosfamide Tris and Doxorubicin","Palonosetron (Aloxi) and Dexamethasone","Palonosetron (PALO)","Palonosetron - Single Dose","Palonosetron - Triple Dose","Pamiparib","panitumumab","Panitumumab, Gemcitabine, Oxaliplatin, Capecitabine","Panitumumab-IRDye800","Panobinostat","panobinostat (LBH589)","Panobinostat (LBH589), Sorafenib","Pantoprazole","Panzem Nanocrystal Colloidal Dispersion","Panzem NCD","PARP Inhibitor BGB-290","PAS-004","Pasireotide","Pasireotide LAR","Pasireotide LAR and Everolimus Combination","Pasireotide LAR followed by Pasireotide LAR + Everolimus","Pasireotide lon acting release formulation","Pasireotide sub-cutaneous formulation","Patient treated by Avapritinib in real life","Patients starting a treatment with Doxorubicin and Ifosfamide","Patupilone","Paxalisib (GDC-0084)","Pazopanib","Pazopanib (GW786034)","pazopanib + gemcitabine","Pazopanib 400 mg QD - Gemcitabine and Docetaxel in Combination","Pazopanib 5 MG","Pazopanib 800 mg","Pazopanib and Paclitaxel","Pazopanib Hydrochloride","pazopanib or guideline conform chemotherapy","Pazopanib Oral Tablet [Votrient]","Pazopanib plus Gemcitabine","PAZOPANIB treatment","PBA-0405","PBI-200","PCI-24781","PCV","PCV chemotherapy","PCV chemotherapy alone","PD 0332991","PD- 0332991","PD-0325901","PD-1 inhibitor","PD-1 Ligand Inhibitor","PD1 antibody","PD1 Inhibitor","PDR001","PDR001, Imatinib","PEG- BCT-100","PEG-filgrastim","Pegamotecan","Pegcetacoplan","Pegfilgrastim","Pegfilgrastim 6mg","Peginterferon-alpha 2b (PegIFNa2b);","PegLiposomal Doxorubicin","pegylated arginine deiminase","Pegylated G-CSF","Pegylated interferon alpha-2b","Pegylated Interfon Alpha 2B","pegylated liposomal doxorubicin","pegylated liposomal doxorubicin hydrochloride","pegylated liposomal doxorubicin, cyclophosphamide, vincristine,","Pembrolizumab","Pembrolizumab (MK-3475)","Pembrolizumab + Lenvatinib","Pembrolizumab + sEphB4-HSA","Pembrolizumab - additional treatment","Pembrolizumab 25 MG\/1 ML Intravenous Solution","Pembrolizumab 25 MG\/ML","Pembrolizumab 25 MG\/ML [Keytruda]","Pembrolizumab 25 MG\/ML [KEYTRUDA\u00ae]","Pembrolizumab adjuvant","Pembrolizumab and Olaparib","Pembrolizumab at 14 days post","Pembrolizumab at 35 days post","Pembrolizumab at 7 days prior","Pembrolizumab Injectable Product","Pembrolizumab Injection [Keytruda]","Pembrolizumab or Nivolumab","Pembrolizumab with All-Trans Retinoic Acid","Pembrolizumab, Eftilagimod alpha","Pembrolizumab, Etoposide, Cisplatin or Carboplatin","pembrolizumab, pazopanib","Pembrolizumab, Vactosertib","Pemetrexed","pemetrexed disodium","pemetrexed+cisplatin","Pemetrexed, cisplatin","Pemigatinib","PEN-866","Penpulimab","PEP-CMV","PEPIDH1M vaccine + vorasidenib","Peposertib","Perampanel","perfosfamide","Perifosine","Personalized drug combination","pertuzumab","Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf","PET imaging with 18F fluciclovine","PET scan with 124I-cRGDY-PEG-dots","Pevonedistat","Pexidartinib","PF-00299804","PF-03084014","PF-04691502","PF-04691502 in combination with Letrozole","PF-05212384","PF-06801591","PF-06840003","PGL4001","PGL4001 (ulipristal) and iron","PGL4001 10 mg","PGL4001 5 mg","PGL4001 matching placebo and iron","PGL4001, placebo","PGL4001, placebo, drug free period","PGL4001, progestin","PGL4001, progestin, drug free period","PH-762","Phase 1 : Avelumab","Phase 1 : Regorafenib","Phase 1: Cyclophosphamide","Phase 1: Trabectedin","Phase 2 : Avelumab","Phase 2 : Regorafenib","Phase 2: Cyclophosphamide","Phase 2: low-dose Regorafenib","Phase 2: Trabectedin","phenprocoumon","Phentermine \/ Topiramate Extended Release Oral Capsule [Qsymia]","phenylacetate","Phenylbutyrate","Phenytoin","photodynamic therapy","Photofrin (porfimer sodium) & photodynamic therapy.","Piamprimab (AK105)","Picato gel","Pictilisib","Pimasertib","Pimicotinib(ABSK021)","Pimitespib","pimivalimab","Pimonidazole","Pioglitazone Oral Product","pirarubicin","Pirarubicin, Ifosfamide","Pirfenidone","Pitavastatin calcium","Pixatimod","Placebo","Placebo (for Pazopanib)","Placebo (for Syntocinon)","Placebo (Normal saline)","Placebo + Placebo Add-back","Placebo + surgery","Placebo 40 mg","Placebo Administration","placebo and vitamin D","Placebo Arm","Placebo capsule","Placebo Cediranib","Placebo estradiol","Placebo for E2\/NETA","Placebo for Elagolix","Placebo for Estradiol\/Norethindrone Acetate","Placebo for relugolix","Placebo GnRH antagonist","Placebo group","Placebo in combination with nivolumab","Placebo Oral Tablet","Placebo pill","Placebo tablet","Placebo tablets","Placebo( for misoprostol)","Placebo-matching telotristat etiprate","Placebos","PlaceboSHR7280 tablets blank preparation","Platinum acetylacetonate (1% wt) supported by sol-gel technology functionalized titania","platinum chemotherapy","PLD and IFO","plerixafor","plitidepsin","PLX3397","PLX73086","PLX7486 TsOH","PLX9486","PM01183","PM14","PN-152,243)\/PN-196,444","Poly ICLC","Polyamine Transport Inhibitor AMXT-1501 Dicaprate","Polyethylene Glycol","PolyMVA","polyvinylpyrrolidone-sodium hyaluronate gel","Pomalidomide","Ponatinib","Ponatinib 30 MG","ponatinib hydrochloride","Poor responder group adjuvant chemotherapy","Potassium Iodide","Potassium iodide solution","PP6","PRA-027","Pralsetinib","pralsetinib (BLU-667)","prasterone","pre-surgical chemotherapy","Prednisolone","prednison","prednison and Sirolimus","prednisone","pregabalin","pregabalin\/celecoxib","pregabalin\/placebo","Preoperative chemotherapy","PREOPERAT\u0130VE GnRHa THERAPY (LEUPROLIDE ACETATE) BEFORE SURGERY FOR UTER\u0130N FIBROIDS","preoperative vaginal misoprostol","Preservative Free drop treatment","Preserved drop treatment","Prexasertib","Pro-netupitant\/Palonosetron","PRO95780","Procarbazine Hydrochloride","Proellex","Proellex 12 mg","Proellex 24 mg","Proellex 25 mg","Proellex 50 mg","Proellex\u00ae","Progenta","Progesterone","Progesterone steroid infusion","Progestins","Proleukin","Prolgolimab","Propofol","propranolol","Propranolol Hydrochloride","Protracted Oral Etoposide","PRRT every 5 weeks","PRRT every 8-10 weeks","PRRT with 177Lu-DOTATATE","PRT2527","PRT811","PSC 833","psilocybin","PT217","PTC299","PTK787\/ZK222584","PV-10 (10% rose bengal disodium)","PX-866","PXD101","PXFK Peptide","pyrazoloacridine","PZP115891, PCI-24781","QL1706 (bispecific antibody targeting PD-1 and CLTA-4)","QPOP category 1","QPOP category 2","Quadratus Lumborum Block","Quizartinib","R(+)XK469","Ra-223 Dichloride","Rabbit anti-thymocyte globulin","Rabbit Antithymocyte Globulin","Racotumomab","RAD001","RAD001 (Everolimus) and Pasireotide (SOM230) LAR","RAD001, everolimus","Radiation therapy","Radioactive iodine-labeled monoclonal antibody omburtamab","Radiosensitive therapy","Radiotherapy and PCV chemotherapy","Radiotherapy+PCV chemotherapy","Raf kinase inhibitor LGX818","Raf\/MEK Inhibitor VS-6766","RAIN-32","Ramosetron","Ramucirumab","ranibizumab","Ranibizumab 2 mg","Ranibizumab injection and TTT - ICG based","Ranitidine","rapamycin","Rapamycin (sirolimus)","ravuconazole","RC48-ADC","Realgar-Indigo Naturalis Formulation","rebimastat","REC-2282","received oral letrozole (2.5 mg\/day)and goserelin subcutaneosly (3.6 mg\/month)","Receiving chemotherapeutic or targeted drugs recommended by molecular tumor board.","Recombinant anti-PD-1 humanized monoclonal antibody injection","Recombinant anti-tumor and anti-virus protein for injection (Novaferon)","Recombinant Human Adenovirus Type 5 Injection","Recombinant human endostatin","recombinant human endostatin,temozolomide,irinotecan","Recombinant Human IL12\/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)","Recombinant Human Thrombopoietin","Recombinant humanized anti-PD-1 monoclonal antibody for injection","Recombinant L-IFN adenovirus injection","Recombinant NV-A01 adenovirus injection","Recombinant oncolytic herpes simplex virus type 1 (R130)","Recombinant oncolytic herpes simplex virus type \u2160 (R130)","Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF)","Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594)","Reduced-intensity maintenance chemotherapy","Regorafenib","Regorafenib (BAY73-4506)","Regorafenib (BAY73-4506, Stivarga\u00ae)","Regorafenib (Stivarga, BAY73-4506)","Regorafenib 160mg or 120mg","Regorafenib 20MG","Regorafenib 40 MG","Regorafenib 40 MG Oral Tablet","regorafenib tablet","Relatlimab","Relatlimab and nivolumab fixed dose combination (FDC)","Relugolix","Relugolix (40 mg) \/estradiol (1 mg)\/norethisterone acetate (0.5 mg) oral tablet","Relugolix + Estradiol + Norethindrone Acetate","Relugolix Placebo","Relugolix-Containing Product","Remifentanil","Remifentanil, propofol and citanest","Repaglinide","Resection\/Treatment with Niraparib","resiquimod","retaspimycin hydrochloride (IPI-504)","Retifanlimab","Retinoic acid","RG1507","Rhenium Re 188-P2045","rhIL-7","rhTPO","Ribociclib","ridaforolimus","Rifampin","rIL-2","Rintatolimod","Ripretinib","Ripretinib Oral Tablet","Ripretinib treatment","ritonavir","Rituximab","Rivaroxaban","Rivaroxaban 10 MG","Rivaroxaban 20 MG","Rivoceranib","Rivoceranib Mesylate, Paclitaxel","RMC-4630","Ro 24-7429","RO5045337","RO5509554","RO7293583","Rocroniom, Non Depolarizing Muscle Relaxant","Rocuronium","Rogaratinib","Rolapitant","Rolapitant Hydrochloride","romidepsin","Romiplostim","Ropidoxuridine","ropivacaine","Rose bengal disodium","rosiglitazone maleate","Rozanolixizumab","RPH-075","rubitecan","Rucaparib","Rucaparib Camsylate","Ruxolitinib","Ruxolitinib Phosphate","S-Gboxin","Sacituzumab Govitecan","Sacituzumab Govitecan-hziy","Saline","Saline Solution","Samotolisib","Sandostatin LAR","Sandostatin long acting release (LAR) Depot (somatostatin analogue)","Sapanisertib","saquinavir mesylate","SAR260301","saracatinib","Sargramostim","Sativex","Satoreotide tetraxetan","satoreotide trizoxetan","Satoreotide trizoxetan 30-45\u03bcg","Satoreotide trizoxetan 5-20\u03bcg","Savolitinib","Saxenda","SB939","SC-002","SD-101","Seclidemstat","Selinexor","Selinexor 20 MG","Selpercatinib","Selumetinib","Selumetinib (AZD6244 hyd sulfate) 25mg\/m2","Selumetinib (AZD6244 hyd sulfate) 50mg\/dose","Selumetinib Sulfate","Selumetinib, 100mg","Selumetinib, 125mg","Selumetinib, 150mg","Selumetinib, 175mg","Selumetinib, 200mg","Selumetinib, 225mg","semaxanib","Seneca Valley Virus (biological agent)","sEphB4-HSA","Sequential chemotherapy - 3 courses of AI","SF1126","SGI-110 (guadecitabine)","SGN-30 (monoclonal antibody)","SGN-CD47M","Sham Treatment","SHR-1210","SHR-1210 Plus Apatinib","SHR-1210+Apatinib","SHR7280 dry suspension","SHR7280 tablets","SI-053","Signifor","Sildenafil","sildenafil citrate","Siltuximab","Siltuximab Matching Placebo","Simmtecan, 5-FU and l-LV","Simvastatin","Simvastatin 40mg","single dose misoprostol","single dose of CART-GFRa4 cells","Single intratumoral injection of DNX-2401","Single-agent chemotherapy","Sintilimab","Sintilimab plus Bevacizumab","Sintilimab plus Bevacizumab and Temozolomide","Sintilimab plus chemotherapy","Sintilimab\uff0cSurufatinib","sirolimus","Sirolimus Albumin-bound Nanoparticles","sirolimus and cyclophosphamide","Sirolimus and hydroxychloroquine","Sirolimus combined with CP, MT and ZA","Sirolimus Oral Product","Sirolimus(0.7mg\/m2)","Sirolimus(0.8mg\/m2)","Sitravatinib Malate","SLC-391","Sm-EDTMP","SNC-109 CAR-T Cells","SNC115 injection","SNX-5422","soblidotin","Sodium chloride 0.9%","sodium stibogluconate","Sodium Thiosulfate","Solanezumab","Soliris","SOM230","SOM230 alone or in combination with RAD001.","Somatostatin analog","Somatostatin-Analog","Somatuline ATG","sonidegib","SOR007 (Uncoated Nanoparticle Paclitaxel) Ointment","Sorafenib","Sorafenib (BAY-43-9006)","Sorafenib (Nexavar)","Sorafenib (Nexavar), Dacarbazine (DTIC)","Sorafenib and Dacarbazine","Sorafenib and Temozolomide","Sorafenib at a dose of 800 mg \/ day","sorafenib tosylate","Sotorasib","SP-2577","SP-2577 Seclidemstat","Spartalizumab","SPH4336","SQ3370","SRA737, gemcitabine","SRA737, gemcitabine, cisplatin","SS-LAR","SSG & interferon","ST-1898 tablets","ST101","ST571 + BYL719","STA-4783","STA-9090","Standard","Standard arm: Trabectedin in monotherapy","Standard chemotherapy","Standard of Care","Standard of care + chemotherapy","Standard supportive therapy","Standard Temozolomide","Standard treatment (as per protocol ISG SSG III)","Standard-of-Care Immunotherapy","Standard-vaginal misoprostol","STAT3 Inhibitor WP1066","Stereotactic biopsy followed by stereotactical photodynamic therapy with 5-aminolevulinic acid","Stereotactic Body Radiation Therapy (SBRT)","Sterile Compound C31510 for Injection","Steroids","STI-1386","STI571","stop oral angiogenesis inhibitor","STZ-5FU","SU011248","SU101","SU5416","Sulfatinib","sulindac","Sunitiinb and Ketoconazol","Sunitinib","Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]","Sunitinib 37.5Mg Oral Capsule","Sunitinib 5 MG","Sunitinib and Ketoconazol","Sunitinib Capsules","Sunitinib malate","Sunitinib Malate (SU011248)","Sunitinib Malate + Valproic Acid","sunitinib malate dose escalation","sunitinib, docetaxel, cisplatin","Sunitinib, Imatinib dosage, Dasatinib, Reveratinib","supersaturated calcium phosphate rinse","surufatinib","Surufatinib + envafolimab","Surufatinib plus chemotherapy","Surufatinib plus Toripalimab","SurVaxM","Sutent","Sutent (sunitinib)","SX-682","Sym004 - 18 mg\/kg","Sym004 - 24 mg\/kg","Syngeneic Lymphocytes (CD4+) Cultured with OKT3 (Ortho) and Interleukin-2 (Chiro","Syntocinon","Systemic multimodal analgesia administered intravenously","Systemic Treatment (T)","T-VEC","tacrolimus","Tacrolimus ointment","Tadalafil","TAK-228","TAK-385","TAK-676","TAK-733","talabostat mesylate","Talazoparib","Talimogene laherparepvec","Talimogene Laherparepvec (T-VEC)","Talimogene Laherparepvec 100000000 PFU\/1 ML Injection Suspension [IMLYGIC]","talotrexin","Tamoxifen","Tamoxifen + Palbociclib","Tamoxifen 20 mg","tamoxifen citrate","Tamoxifen or Aromatase Inhibitor or Aromatase Inhibitor + goserelin","tanespimycin","Tarceva (Erlotinib Hydrochloride)","Tarceva and Rapamycin","target treatment","Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection","Targeted Molecular Therapy","TAS-102","TAS-102 (trifluridine and tipiracil, Lonsurf\u00ae)","TAS-117","TAS-120","Tasigna","Tasonermine (TNFa)","Tazarotene Cream 0.1%","Tazemetostat","TB-403 100mg\/kg","TB-403 175mg\/kg","TB-403 20mg\/kg","TB-403 50mg\/kg","TBI-1301","Tc 99m tilmanocept","Tc99m-tilmanocept","Td vaccine","Tebentafusp","Tebentafusp with Pembrolizumab","Tebentafusp-Tebn","Tecentriq 1200 MG in 20 ML Injection","Technetium Tc-99m Sodium Pertechnetate","Tecogalan sodium","Tegafur","Tegavivint","Telaglenastat Hydrochloride","Telapristone Acetate","telepristone acetate 12 mg","telepristone acetate 24 mg","telepristone acetate 3 mg","telepristone acetate 6 mg","Telotristat (High-Dose)","Telotristat (Low-Dose)","Telotristat Ethyl","Telotristat etiprate","TEMIRI","Temodal","Temodal\/radiotherapy","Temodar","Temozolimide + Irinotecan","Temozolomide","Temozolomide (Temodal)","Temozolomide (TMZ)","Temozolomide + TACE","Temozolomide according Stupp protocol","Temozolomide adjuvant chemotherapy","Temozolomide and Accelerated Hypofractionation RT","temozolomide and bevacizumab","Temozolomide and SU11248","Temozolomide capsule","Temozolomide for injection combined with epirubicin","temozolomide or dacarbazine-based chemotherapy, endostatin","Temozolomide Oral Product","Temozolomide+Irinotecan+Vincristine","temozolomide, thiotepa","temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid","Temozolomide\/Hycamtin (Topotecan)","Temsirolimus","temsirolimus plus liposomal doxorubicin","Terameprocol","Tesetaxel","Tetracaine 0.5%","TG02 capsules oral administration, BIW in every 28d","TGR-1202","TH-302","TH-302 (escalating) with bevacizumab 10mg\/kg","TH-302 + Sunitinib","TH-302 in Combination with Doxorubicin","TH-302 preoperative","thalidomide","Thalomid","the drug of intravenous patient-controlled analgesia","therapeutic allogeneic lymphocytes","therapeutic angiotensin-(1-7)","thioguanine","Thiotepa","thiotepa, carboplatin, etoposide","Thymoglobulin","Tigilanol Tiglate","TIL","Tin ethyl etiopurpurin","Tinostamustine (EDO-S101)","Tipifarnib","Tiragolumab","tirapazamine","Tislelizumab","Tislelizumab plus Bevacizumab","tivozanib","Tizanidine","TJ107","TJ107 placebo","TK216","TLC 388","TLR4 Agonist GLA-SE","TLR8 Agonist VTX-2337","TMZ","TMZ plus CDDP","TMZ plus concurrent re-irradiation","TNG462","TNG908","TNO155","TNO155 in combination with EGF816 (nazartinib)","TNP-470","Toca FC","Tocilizumab","Tolbutamide","Tolcapone","Tolinapant","Topical application Tranexamic acid","Topotecan","topotecan hydrochloride","Topotecan, Cyclophosphamide, Cisplatin, Doxorubicin, Etoposide, Ifosfamide, Carboplatin","Topotecan, Temozolomide","toremifene","Toripalimab","Toripalimab and Anlotinib","Toripalimab Combined With CAV \/ IE Regimen chemotherapy","Toripalimab Combined With CAV\/IE chemotherapy","Toripalimab combined with Temozolomide","TORIPALIMAB INJECTION(JS001 ) Axitinib tablet (Inlyta\u00ae)","Tovorafenib","TP-1287","TP-38","TP38","TPI 287","TQ Formula (black seed oil capsules)","TQB2450","TQB2450 injection","TQB2858 injection","TQB3525","TQB3616 capsule","TQB3616 placebo","Trabectedin","Trabectedin (ecteinascidin-743, ET-743, YONDELIS [R])","Trabectedin 0.25 MG\/1 VIAL Intravenous Powder for Solution","Trabectedin 1 MG [Yondelis]","trabectedin 1.3 mg\/m2","Trabectedin continuation","Trabectedin discontinuation","Trametinib","Trametinib 2 mg daily","Trametinib 2.0 mg","Trametinib Dimethyl Sulfoxide","Trametinib plus hydroxychloroquine in patients with NRAS Melanoma (Dose 1)","Trametinib plus hydroxychloroquine in patients with NRAS Melanoma (Dose 2)","Trametinib plus hydroxychloroquine in patients with NRAS Melanoma (Dose 3)","Tranexamic Acid","Tranexamic Acid (TXA)","Tranexamic Acid 100 MG\/ML","Tranexamic acid injection","tranexamic acid tablets","Trans Sodium Crocetinate (TSC)","TransCon IL-2 \u03b2\/\u03b3","TransCon TLR7\/8 Agonist","Trastuzumab","Trastuzumab after SubQ GM-CSF","trastuzumab emtansin","Trastuzumab Emtansine","Trastuzumab in combination with SubQ GM-CSF","Trastuzumab\/Hyaluronidase-oysk","Traumeel S","TRC105 and Pazopanib","Treatment by Placebo","Treatment by placebo and best supportive care","Treatment by Regorafenib","Treatment by regorafenib and best supportive care","Treatment with CD200AR-L","Treatment with MTX110","Tremelimumab","Treosulfan","tretinoin","Triamcinolone","Triamcinolone Acetonide","Triamcinolone Acetonide 40mg\/mL","Triapine","Trifluridine and Tipiracil","Trifluridine\/Tipracil","Trilaciclib","trimetrexate glucuronate","TRIN2755","Triplet therapy","Triptorelin 3.75 mg","Trofosfamide","trofosfamide, etoposide","trofosfamide, idarubicin, etoposide","troglitazone","TSD","TSR-042","TTAC-0001","TTAC-0001 and pembrolizumab combination","TTI-621","TTI-621 + PD-1\/PD-L1 Inhibitor","TTI-621 + pegylated interferon-\u03b12a","TTI-621 Monotherapy","Tucatinib","Tucidinostat and etoposide","Tucidinostat, Apatinib","Tumor Necrosis Factor","Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)","Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy","Tumor Purged\/CD25 Depleted Lymphocytes","Tuparstobart","Turalio","TURALIO(R)","TURALIO\u2122","Tuvusertib","TVB-2640","TWP-101","tyrosinase peptide","Tyrosine kinase inhibitors other than avapritinib ( imatinib, sunitinib, et al )","Ubamatamab","UB_TT170","Ulipristal","ulipristal acetate","Ulipristal acetate (UPA)","Ulipristal Acetate - open label","Ulipristal Acetate 5 mg","Ulipristal Acetate 5 MG Oral Tablet","Ulixertinib","Ultra-low dose Bevacizumab","Ultratrace Iobenguane I 131","UltratraceTM Iobenguane I 131 Imaging","UltratraceTM Iobenguane I 131 Therapy","undefined","Unesbulin","Uprosertib","Ursodiol","usage oral angiogenesis inhibitor","USL311","Vactosertib","vactosertib\/imatinib combination","Vaginal placebo+ oral placebo","VAL-413","Valacyclovir","valganciclovir","Valganciclovir (VGC)","Valganiclovir","Valproate","Valproic Acid","Vandetanib","Vandetanib 300 mg","Vandetanib\/Metformin","Vasopressin","vatalanib","VCR, CTX, ADM; IFO, VP-16","VDC-IE","VDC-IE x2","VEC","VEC + HD-MTX","VEGF inhibitor PTC299","Velcade (PS-341, Bortezomib)","veliparib","vemurafenib","Vemurafenib (Zelboraf\u00ae)","Vemurafenib and Cobimetinib","Venetoclax","verteporfin","Verzistobart","Vesnarinone","VIA combination treatment","Vilaprisan (BAY1002670","Vilaprisan (BAY1002670)","Vilaprisan, BAY1002670","vimseltinib","VIN","Vinblastin Maintenance","Vinblastine","Vinblastine + Nilotinib","vinblastine sulfate","Vincristine","Vincristine (Cellcristin\u00ae)","vincristine sulfate","Vincristine Sulfate Liposome","Vincristine, Actinomycin-D, Ifosfamide","vincristine, adriamycin and cytoxan, alternating with ifosfamide VP-16","vincristine, carboplatin","vincristine, carboplatin, etoposide","Vincristine, Irinotecan","Vincristine, Irinotecan, Temozolomide","Vindesine","vinorelbine","vinorelbine tartrate","Vinorelbine, cyclofosfamide","Vismodegib","Vital Blue Dye (optional)","Vitamin D","Vitamin D 3","Vitamin D3 400 UNT Oral Capsule","VLS-1488","volociximab","Vorasidenib","voriconazole","Vorinostat","Vorinostat (SAHA)","Vorinostat and Etoposide","Vorinostat Oral Capsule","Votrient","WHG626","women receiving misoprostol","women receiving tranexamic acid","Xermelo","Xevinapant","XGEVA\u00ae","XL184","XL820","XmAb18087 \u00b1 Pembrolizumab","XmAb20717","XON7","Y90-DOTA-Tyr3-Octreotide","Yervoy","YF476","YH001","YH003","Yondelis","YYB-103","Z-Endoxifen","Zalcitabine","Zalypsis","ZD6474","ZD6474 (Vandetanib)","ZGN-440 for injectable suspension","ZGN-440 sterile diluent","Zidovudine","Zimberelimab","Zinecard","ZIO-201","ZIO-201-T and doxorubicin","ziv-aflibercept","ZKAB001 10mg\/kg","ZKAB001 15mg\/kg","ZKAB001 5mg\/kg","ZN-c3","Zoledronate","Zoledronic acid","Zolendric acid","[123I] metaiodobenzylguanidine","[124I]meta-Iodobenzylguanidine","[177Lu]Lu-NeoB","[177]Lu-DOTA-TATE","[18 F]-6-L-fluorodihydroxyphenylalanine (18F-FDOPA)","[18F]-DOPA","[18F]-FLT-PET\/CT scans","[68Ga]Ga-DOTA-TATE","[68Ga]Ga-NeoB","[68Ga]Pentixafor","[68]Ga-HA-DOTATATE","[6R] 5,10-methylenetetrahydrofolate (arfolitixorin)","[89Zr]Zr-BI 764532","[90]Y-DOTATOC","^1^1C-methionine","^1^8F-fluorodeoxyglucose","\u2022 TF2 and 68 Ga-IMP-288","test"]